Suvretta Capital Management, LLC has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $2.54 Billion distributed in 98 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Kura Oncology, Inc. with a value of $150M, Insmed Inc with a value of $119M, Intra Cellular Therapies, Inc. with a value of $105M, Arcutis Biotherapeutics, Inc. with a value of $99.7M, and Meta Platforms, Inc. with a value of $96.4M.
Examining the 13F form we can see an increase of $147M in the current position value, from $2.39B to 2.54B.
Suvretta Capital Management, LLC is based out at New York, NY
Below you can find more details about Suvretta Capital Management, LLC portfolio as well as his latest detailed transactions.
Portfolio value
$2.54 Billion
Healthcare: $1.18 Billion
Technology: $335 Million
ETFs: $331 Million
Consumer Cyclical: $239 Million
Communication Services: $201 Million
Financial Services: $147 Million
Consumer Defensive: $68.7 Million
Industrials: $37.8 Million
Other: $1.86 Million
Stock Holdings Table Market Cap. of $10 Billions to $200 Billions
